Text Only
Full media Version


The Emergency Contraception Website - Your website for the "Morning After"

Get Emergency Contraception NOW

Under 17?

 

In the U.S., Plan B One-Step is available without age restrictions to women and men (check the family planning aisle). One-pill generics (My Way and Next Choice One Dose) will soon be available on the shelf for consumers aged 17 and older, but this change has not taken effect yet; women aged 16 and younger still need a prescription. Two-pill generics (Levonorgestrel Tablets) are still available only behind the counter without prescription if you are 17 or older; younger women need a prescription

 

There are different regulations on how to purchase the different emergency contraceptive pills available in the United States, so it can be a bit confusing. Always call the pharmacy first to find out which brands of EC are in stock.

  • Plan B One-Step is sold on the shelf (check the family planning aisle) with no restrictions. That means anyone can buy it without having to show ID. Plan B One-Step generally costs about $40-50.
  • Soon, the generic one-pill products (Next Choice One Dose and My Way) will be available on the shelf next to Plan B One-Step, but you need to be 17 to buy them. Be prepared to show ID to buy these products. These generics generally cost about $35-45
  • The generic two-pill products Levonorgestrel Tablets are still available only at the pharmacy counter. Women and men aged 17 or older can buy them without a prescription. If you are 16 or younger, you need a prescription.
  • ella is sold by prescription only, regardless of age. You can also order ella through an online prescription service (if you are 14 or older) for $42, including next-day shipping.

lt is great news that Plan B One-Step is now available for anyone to buy, directly on the shelf, but it can be very expensive. If cost is an issue, you may want to find a family planning clinic that offers EC for a reduced rate.


Back

This website is operated by the Office of Population Research at Princeton University and by the Association of Reproductive Health Professionals and has no connection with any pharmaceutical company or for-profit organization.

website design by DDA